The Blueprint for Longevity: Takeaways from the NUS Unlock Healthy Longevity Conference 2026

Singapore: The Blueprint for Blue Zone 2.0 and the Future of Geromedicine

After three years of rapid evolution, This isn’t just about wellness – it’s about a rigorous, scientific, and evidence-based approach to human healthspan, the Unlock Healthy Longevity Conference at the National University of Singapore (NUS) has officially cemented its place as the world’s leading longevity event.

With over 500 attendees from 40+ countries, it was clear that Singapore is no longer just a financial hub; it is the global laboratory for Blue Zone 2.0. I’m back from the front lines with a short recap from my lens of the technologies and molecules that are actually moving the needle, as well as some the most interesting people I had a honor meeting.

The shift is clear: we are moving away from reactive “sick-care” toward a proactive, scientific, and community-driven approach to targeting aging itself.

Mentoring the Next Frontier: The Startup Pitch Winners

Serving as a judge for the Startup Pitch Competition was a highlight of the event. Collaborating with Clarice Chen (Director at Enterprise Singapore) and John Zhang (Senior Commercial Director at NovogeneAIT Genomics) was an honor, though our task was difficult given the level of innovation on display.

After evaluating rigorous criteria from scientific depth to clinical traction, we are proud to announce the winners:

1. 1st Place: MenSC Labs – A revolutionary approach to regenerative medicine, leveraging menstrual blood as a scalable, non-invasive, and affordable source of mesenchymal stem cells (MSCs) for cartilage repair and wound healing.
2. 2nd Place: LATERAL PHARMA PTY LTD – Developing a first-in-class drug platform (SCP drugs) targeting the LanCL protein family to protect cell health under stress, inflammation, and damage.
3. 3rd Place: Myomar Molecular – Pioneering the world’s first urine-based muscle health test to combat sarcopenia through personalized metabolism monitoring.

Congratulations to all the startups that presented, including those in the flash pitches like my favorite AiTreat Pte. Ltd. that is being tested at the Mayo Clinic, you are all winners by making it this far on the global longevity stage, so keep innovating because you are the backbone for what is to come.

The Science of Molecules: From “Longevity Vitamins” to Mitophagy

The technical sessions provided a masterclass in how we target the biological hallmarks of aging.

The “Longevity Vitamin”: Ergothioneine

We spent significant time on Ergothioneine (ERGO). This magical compound is now being considered a “longevity vitamin” due to its potent antioxidant and anti-inflammatory properties and thanks to legends like Prof Barry Halliwell and Robert B. Beelman.

• Source: Highly bioavailable in mushrooms, particularly Mushrooms like Gray Oyster White Button, Shiitake, and diets containing Tempe and Kidney Bean.
• Ecosystem Connection: Interestingly, ERGO levels in food are tied to soil health. Regenerative agriculture isn’t just good for the planet; it’s essential for our cellular resilience.

Pomegranate & Brain Resilience: Urolithin A

Evandro Fei Fang presented groundbreaking research on Urolithin A, a natural metabolite derived from ellagitannins found in pomegranates. It works by stimulating mitophagy, the process by which your cells clear out damaged mitochondria, which is vital for brain resilience and muscle health.

NAD+ Metabolism & Precursors

Vincenzo SORRENTINO led the Metabolism Modulation session on one of the most popular molecule NAD⁺, focusing on how precursors like NR and NMN are moving from experimental targets to standard protocols for age-associated diseases.

The Fringe Moving Toward the Center: Psilocybin & Cannabinoids

One of the most exciting shifts this year was the presence of research on compounds once considered “alternative.” Psilocybin was mentioned multiple times by the legendary Vasso Apostolopoulos AM from RMIT University, showing very promising evidence-based research for neuro-longevity and inflammatory regulation. The Lambert Initiative for Cannabinoid Therapeutics even showcased how hemp-derived Cannabinoids molecules are being advanced for frailty and cognitive impairment.

Precision Geromedicine: AI & Aesthetics

The exhibition hall was alive with innovation – diagnostics are becoming personalized, smaller, faster, and more affordable.

• AI in Senescence: We saw computational approaches using Deep Neural Networks to predict “zombie cells” (senescence) with real-world clinical application presented by Morten Scheibye-Knudsen.
• The Science of Skin: Magali Moreau from L’Oréal demonstrated that skin is a primary biomarker of aging. We discussed Rosemary extract and Okra Seed extracts as potent tools to mitigate skin photoaging.

Ecosystem & Capital: Accelerating Translation

As Dr. Lars Hartenstein and Allen Law emphasized, science cannot exist in a vacuum. We need cross-sector collaboration between academia, healthcare, and investment.

• Government Initatives: Hian Chuan (Henry) Kwek highlighted promising capital investment strategies from the Singaporean government to accelerate precision geromedicine.
• Clinical Integrity: Manjit Sareen and Dushani L. Palliyaguru, Ph.D. spoke on the “Beyond Hype” necessity of validating nutraceuticals in a clinical setting to ensure safety and transparency in the supply chain.